Literature DB >> 9783564

Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.

W H Kaye1, C G Greeno, H Moss, J Fernstrom, M Fernstrom, L R Lilenfeld, T E Weltzin, J J Mann.   

Abstract

BACKGROUND: Women with bulimia nervosa (BN) have disturbances of mood and behavior and alterations of monoamine activity when they are bingeing and purging. It is not known whether these alterations are secondary to pathological eating behavior or traits that could contribute to the pathogenesis of BN.
METHODS: To avoid the confounding effects of pathological eating behavior, we studied 30 women after long-term recovery (>1 year with no bingeing or purging, normal weight, and regular menstrual cycles) from BN. Subjects were compared with 31 healthy volunteer women. We assessed psychiatric diagnoses and symptoms to determine whether there was any persistent disturbance of behavior after recovery. We measured cerebrospinal fluid (CSF) levels of the major metabolites of serotonin (5-hydroxyindoleacetic acid [5-HIAA]), dopamine (homovanillic acid [HVA]), and norepinephrine (3-methoxy-4-hydroxyphenylglycol [MHPG]) as well as hormonal and behavioral response to m-chlorophenylpiperazine (m-CPP), a serotonin-specific agent.
RESULTS: Women who were recovered from BN had mild to moderate negative moods and obsessions with perfectionism and exactness and exaggerated core eating disorder symptoms compared with healthy volunteer women. Recovered BN women had increased levels of CSF 5-HIAA compared with control women (117 +/- 33 vs 73 +/- 15 pmol/mL; P< or =.001) but normal CSF HVA and MHPG concentrations. Recovered BN women had an anxious and disorganized behavioral response to m-CPP but a normal hormonal response.
CONCLUSIONS: Persistent serotonergic and behavioral abnormalities after recovery raise the possibility that these psychobiological alterations might be trait-related and contribute to the pathogenesis of BN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783564     DOI: 10.1001/archpsyc.55.10.927

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  29 in total

1.  Treatment improves serotonin transporter binding and reduces binge eating.

Authors:  Liisa I Tammela; Aila Rissanen; Jyrki T Kuikka; Leila J Karhunen; Kim A Bergström; Eila Repo-Tiihonen; Hannu Naukkarinen; Esko Vanninen; Jari Tiihonen; Matti Uusitupa
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

2.  The relationship between alexithymia and maladaptive perfectionism in eating disorders: a mediation moderation analysis methodology.

Authors:  S Marsero; G M Ruggiero; S Scarone; S Bertelli; S Sassaroli
Journal:  Eat Weight Disord       Date:  2011-09       Impact factor: 4.652

3.  5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.

Authors:  Ursula F Bailer; Cinnamon S Bloss; Guido K Frank; Julie C Price; Carolyn C Meltzer; Chester A Mathis; Mark A Geyer; Angela Wagner; Carl R Becker; Nicholas J Schork; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2010-09-24       Impact factor: 4.861

4.  Challenges in conducting a multi-site randomized clinical trial comparing treatments for adolescent anorexia nervosa.

Authors:  James Lock; Harry Brandt; Blake Woodside; Stewart Agras; W Katherine Halmi; Craig Johnson; Walter Kaye; Denise Wilfley
Journal:  Int J Eat Disord       Date:  2011-04-14       Impact factor: 4.861

Review 5.  Genetics of eating disorders.

Authors:  Anke Hinney; Anna-Lena Volckmar
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

6.  Serotonin transporter binding after recovery from bulimia nervosa.

Authors:  Rama Pichika; Monte S Buchsbaum; Ursula Bailer; Carl Hoh; Alex Decastro; Bradley R Buchsbaum; Walter Kaye
Journal:  Int J Eat Disord       Date:  2011-06-13       Impact factor: 4.861

7.  Significant linkage on chromosome 10p in families with bulimia nervosa.

Authors:  Cynthia M Bulik; B Devlin; Silviu-Alin Bacanu; Laura Thornton; Kelly L Klump; Manfred M Fichter; Katherine A Halmi; Allan S Kaplan; Michael Strober; D Blake Woodside; Andrew W Bergen; J Kelly Ganjei; Scott Crow; James Mitchell; Alessandro Rotondo; Mauro Mauri; Giovanni Cassano; Pamela Keel; Wade H Berrettini; Walter H Kaye
Journal:  Am J Hum Genet       Date:  2002-12-10       Impact factor: 11.025

8.  Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.

Authors:  Ursula F Bailer; Guido K Frank; Julie C Price; Carolyn C Meltzer; Carl Becker; Chester A Mathis; Angela Wagner; Nicole C Barbarich-Marsteller; Cinnamon S Bloss; Karen Putnam; Nicholas J Schork; Anthony Gamst; Walter H Kaye
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

Review 9.  Neurobiology of anorexia and bulimia nervosa.

Authors:  Walter Kaye
Journal:  Physiol Behav       Date:  2007-11-29

Review 10.  Eating disorders: the current status of molecular genetic research.

Authors:  Susann Scherag; Johannes Hebebrand; Anke Hinney
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-12-24       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.